Appropriate Designations of the Roles of Sponsor and Sites in Data Processing Agreements (DPA) in Clinical Trial Agreements (CTA)

As part of its advocacy program, ACRO submits feedback to foster alignment across industry bodies and regulators. A white paper exploring the inconsistent application of definitions of sponsors and investigators/sites with respect to what party is an independent/joint controller and processor of trial participant personal data in the EU can be found below. This white paper seeks to align with the IPMPC with a view to appropriately positioning the issue with EFPIA for the purposes of engaging with the EDPB.

Appropriate Designations of the Roles of Sponsor and Sites in Data Processing Agreements (DPA) in Clinical Trial Agreements (CTA)

Scroll to Top